EG19304A - Method of treating pre-menstrual syndrome - Google Patents

Method of treating pre-menstrual syndrome

Info

Publication number
EG19304A
EG19304A EG1690A EG1690A EG19304A EG 19304 A EG19304 A EG 19304A EG 1690 A EG1690 A EG 1690A EG 1690 A EG1690 A EG 1690A EG 19304 A EG19304 A EG 19304A
Authority
EG
Egypt
Prior art keywords
menstrual syndrome
treating pre
pms
menstrual
syndrome
Prior art date
Application number
EG1690A
Other languages
English (en)
Inventor
Michael Cohen
Original Assignee
Michael Cohen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27154756&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG19304(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Michael Cohen filed Critical Michael Cohen
Application granted granted Critical
Publication of EG19304A publication Critical patent/EG19304A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
EG1690A 1989-01-17 1990-01-14 Method of treating pre-menstrual syndrome EG19304A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/297,328 US4945103A (en) 1989-01-17 1989-01-17 Method of treating pre-menstrual syndrome
AU51928/90A AU642864B2 (en) 1989-01-17 1990-02-09 Method of treating pre-menstrual syndrome
PCT/US1990/000154 WO1991012007A1 (fr) 1989-01-17 1990-02-09 Procede de traitement du syndrome pre-menstruel
CA002075904A CA2075904C (fr) 1989-01-17 1990-02-09 Methode de traitement du syndrome pre-menstruel

Publications (1)

Publication Number Publication Date
EG19304A true EG19304A (en) 1994-11-30

Family

ID=27154756

Family Applications (1)

Application Number Title Priority Date Filing Date
EG1690A EG19304A (en) 1989-01-17 1990-01-14 Method of treating pre-menstrual syndrome

Country Status (11)

Country Link
US (1) US4945103A (fr)
EP (1) EP0514373B1 (fr)
KR (1) KR0171408B1 (fr)
AT (1) ATE124260T1 (fr)
AU (1) AU642864B2 (fr)
CA (1) CA2075904C (fr)
DE (1) DE69020582T2 (fr)
EG (1) EG19304A (fr)
ES (1) ES2074565T3 (fr)
IL (1) IL93053A (fr)
WO (1) WO1991012007A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116828A (en) * 1989-10-26 1992-05-26 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of osteoporosis
US5707652A (en) * 1990-12-04 1998-01-13 State Of Oregon Methods of treating circadian rhythm phase disorders
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
ATE181670T1 (de) * 1991-05-09 1999-07-15 Neurim Pharma 1991 Melatonin enthaltende arzneimittel
EP0608362A1 (fr) * 1991-10-18 1994-08-03 Alza Corporation Dispositif pour l'administration transdermique de melatonine
EP0565296B1 (fr) * 1992-04-07 1996-08-07 Neurim Pharmaceuticals (1991) Limited Utilisation de mélatine pour la fabrication d'un médicament pour le traitement de l'hyperplasie bénine de la prostate
US5385736A (en) * 1993-07-12 1995-01-31 Minnesota Mining And Manufacturing Company Transdermal melatonin delivery system
AU7550994A (en) * 1993-07-26 1995-02-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Sustained release oral compositions containing melatonin
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
CA2255838A1 (fr) * 1996-05-20 1997-11-27 Richard C. Fuisz Melatonine combinee a des analgesiques
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US6133453A (en) * 1998-05-15 2000-10-17 Pharm-Eco Laboratories, Inc. Method for making substituted indoles
US20040131579A1 (en) * 1998-09-10 2004-07-08 Avon Products, Inc. Method and compositions for reducing dermatological aging and for reducing bruising
US6479545B1 (en) 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
DE19957710A1 (de) * 1999-11-30 2001-05-31 Asat Ag Applied Science & Tech Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US20020119191A1 (en) * 2000-04-24 2002-08-29 Hitoo Nishino Pharmaceutical or food composition for treatment or prevention of brain edema
JP2005513080A (ja) 2001-12-20 2005-05-12 フェムファーマ， インコーポレイテッド 薬物の膣送達
WO2004060322A2 (fr) 2003-01-02 2004-07-22 Femmepharma Holding Company, Inc. Preparations pharmaceutiques permettant le traitement de maladies et d'affections du sein
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
WO2005039546A2 (fr) 2003-10-03 2005-05-06 Veijlen N.V. Utilisation de composes pouvant accroitre le niveau serique d'igf-1 pour preparation d'une composition therapeutique destinee au traitement de divers etats pathologiques associes a un niveau serique d'igf-1 reduit chez les humains et les animaux
DK1667678T3 (da) 2003-10-03 2009-08-24 Veijlen N V Dyrefodersammensætning
KR100835183B1 (ko) * 2006-08-30 2008-06-04 엘지전자 주식회사 냉장고
KR100776294B1 (ko) * 2006-08-30 2007-11-16 엘지전자 주식회사 냉장고
EP2068695A2 (fr) * 2006-09-13 2009-06-17 Koninklijke Philips Electronics N.V. Dispositif de régulation automatique d'une dose de mélatonine et/ou de l'administration de mélatonine
MX2009010878A (es) * 2007-04-11 2010-03-26 John A Mccarty Pastilla de melatonina y metodos de preparacion y uso.
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
KR102262306B1 (ko) 2013-07-04 2021-06-09 (주)아모레퍼시픽 월경 전기 증후군 및 월경통 완화의 기능을 갖는 조성물
KR102192573B1 (ko) 2020-08-12 2020-12-18 문종진 생리통 및 피부 트러블의 예방 및 개선용 조성물
CN113876689A (zh) * 2021-11-01 2022-01-04 冷静 一种改进型褪黑素的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2967049D1 (en) * 1978-04-11 1984-07-19 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
DE3466215D1 (en) * 1983-05-18 1987-10-22 Univ Monash The use of melatonin for the manufacture of a medicament
US4600723A (en) * 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
US4687763A (en) * 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
US4746674A (en) * 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
US4654361A (en) * 1986-01-27 1987-03-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Method of lowering intraocular pressure using melatonin
NZ215767A (en) * 1986-04-09 1989-10-27 Nz Government Stimulating cashmere fibre growth on cashmere-producing goats by administration of melatonin
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
EP0311651A1 (fr) * 1987-04-01 1989-04-19 Cellena (Cell Engeneering) A.G. Derives de melatonine pour stress psychogene et anxiete aigue, et medicaments immuno-stimulants

Also Published As

Publication number Publication date
IL93053A (en) 1994-02-27
EP0514373B1 (fr) 1995-06-28
DE69020582T2 (de) 1996-01-04
CA2075904A1 (fr) 1991-08-10
AU642864B2 (en) 1993-11-04
AU5192890A (en) 1991-09-03
US4945103A (en) 1990-07-31
EP0514373A1 (fr) 1992-11-25
EP0514373A4 (en) 1993-03-17
ES2074565T3 (es) 1995-09-16
KR0171408B1 (ko) 1999-02-01
KR920700649A (ko) 1992-08-10
DE69020582D1 (de) 1995-08-03
WO1991012007A1 (fr) 1991-08-22
CA2075904C (fr) 2004-07-20
ATE124260T1 (de) 1995-07-15

Similar Documents

Publication Publication Date Title
EG19304A (en) Method of treating pre-menstrual syndrome
HU9202072D0 (en) An improved method for treatment of autoimmunic diseases by means of introduction of autoantigenes in form of aerosol
EP0219524A1 (fr) Traitement du syndrome de detresse respiratoire chez l'adulte.
EP0552256A4 (fr)
EP0460912A3 (en) Medicaments for the treatment of sexual disorder
GR3006089T3 (fr)
OA09908A (en) Treatment of neoplastic disease with interleukin-10
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
PT92866A (pt) Metodo para o tratamento de sindroma pre-menstrual, utilizando melatonina
PL285854A1 (en) Therapeutical device, especially for treatment of sexual disorders in men
GR3029726T3 (en) Use of a therapeutic compound for the treatment of bronchitis
ZA832491B (en) Hydantoin therapeutic agents
HUT37030A (en) Therapeutic auxiliary device for the treatment of traumatological patients, first of all with lower limb fraction
MX9700626A (es) USO DE AZASPIRANOS EN LA REPARACIaN DE COMPOSICIONES PARA TRATAR INFECCIONES OPORTUNISTAS.
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
EP0428272A3 (en) Trifluorobenzodiazepine compounds for use in therapy by intraoral administration
PL268278A1 (en) Apparatus for narrowing an invalid's wheel chair
ES2011526A6 (es) Instalacion para la regeneracion y depouracion de la sangre.
GB8721837D0 (en) Therapeutic foot massager
EP0267402A3 (en) Use of follicle regulatory protein for the production of a therapeutic agent for the treatment of neoplasm of gonadal origin
IT1243947B (it) 2-azido-ornitina, sua preparazione e suo impiego in terapia
HUT59823A (en) Sensitivizing composition for ionizing rays and process for producing it
GB8818556D0 (en) Novel therapeutic immunoconjugates for use in treatment of cancer
GB8622419D0 (en) Treatment/therapy for diabetes sufferes